Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM

Rhythm Pharmaceuticals Stock Analysis & Ratings

Rhythm Pharmaceuticals Stock Analysis Overview

Smart Score
2
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Rhythm Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

RYTM

RYTM Stock Stats

Previous Close$7.4
Open$7.59
Bid6.19 x 100
Ask15.19 x 500
Today’s Range$6.66 - $7.69
52-Week Range$6.66 - $35.44
Volume306.13K
Average Volume339.67K
Market Cap$339.31M
Beta1.30
P/E Ratio-5.2
EPS-1.29
Earnings DateMar 09, 2022

Company Description

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc. develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. It focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. The firm rapidly develops setmelanotide for rare genetic disorders of obesity caused by MC4 pathway deficiencies and provides advance setmelanotide for POMC deficiency obesity and LEPR deficiency obesity as first indications in upstream MC4 pathway deficiencies. The company was founded by Bart Henderson in February 2010 and is headquartered in Boston, MA.
Sector
Healthcare
Industry
Biotechnology
CEO
David P. Meeker
Employees
90
Website
http://www.rhythmtx.com
ISIN
US76243J1051
Address
222 Berkeley Street, Boston, MA, 02116, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

RYTM FAQ

What was Rhythm Pharmaceuticals’s price range in the past 12 months?
Rhythm Pharmaceuticals lowest stock price was $6.66 and its highest was $35.44 in the past 12 months.
    What is Rhythm Pharmaceuticals’s market cap?
    Rhythm Pharmaceuticals’s market cap is $339.31M.
      What is Rhythm Pharmaceuticals’s price target?
      The average price target for Rhythm Pharmaceuticals is $26.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $50.00 ,the lowest forecast is $10.00. The average price target represents 288.89% Increase from the current price of $6.75.
        What do analysts say about Rhythm Pharmaceuticals?
        Rhythm Pharmaceuticals’s analyst rating consensus is a ‘Hold. This is based on the ratings of 5 Wall Streets Analysts.
          When is Rhythm Pharmaceuticals’s upcoming earnings report date?
          Rhythm Pharmaceuticals’s upcoming earnings report date is Mar 09, 2022 which is in 40 days.
            How were Rhythm Pharmaceuticals’s earnings last quarter?
            Rhythm Pharmaceuticals released its earnings results on Nov 02, 2021. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.807 by $0.107.
              Is Rhythm Pharmaceuticals overvalued?
              According to Wall Street analysts Rhythm Pharmaceuticals’s price is currently Undervalued.
                Does Rhythm Pharmaceuticals pay dividends?
                Rhythm Pharmaceuticals does not currently pay dividends.
                What is Rhythm Pharmaceuticals’s EPS estimate?
                Rhythm Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Rhythm Pharmaceuticals have?
                Rhythm Pharmaceuticals has 50,270,000 shares outstanding.
                  What happened to Rhythm Pharmaceuticals’s price movement after its last earnings report?
                  Rhythm Pharmaceuticals reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.807. Following the earnings report the stock price went up 14.38%.
                    Which hedge fund is a major shareholder of Rhythm Pharmaceuticals?
                    Among the largest hedge funds holding Rhythm Pharmaceuticals’s share is PRIMECAP Management Co. It holds Rhythm Pharmaceuticals’s shares valued at 81M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis